PubMed ID:
24269922
Public Release Type:
Journal
Publication Year: 2014
Affiliation: Liver Center of Excellence, Digestive Disease Institute, Virginia Mason Medical Center, Seattle, Washington; Benaroya Research Institute, Virginia Mason Medical Center, Seattle, Washington. Electronic address: Kris.kowdley@vmmc.org.
DOI:
https://doi.org/10.1016/j.cgh.2013.11.017
Authors:
Aouizerat B,
Kowdley KV,
NASH Clinical Research Network,
Nelson JE,
Siddique A,
Yeh MM
Studies:
Nonalcoholic Steatohepatitis Clinical Research Network
Iron deficiency is often observed in obese individuals. The iron regulatory hormone hepcidin is regulated by iron and cytokines interleukin (IL) 6 and IL1β. We examine the relationship between obesity, circulating levels of hepcidin, and IL6 and IL1β, and other risk factors in patients with nonalcoholic fatty liver disease (NAFLD) with iron deficiency.